Overview

An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure

Status:
Completed

Trial end date:
2007-06-01

Target enrollment:

Participant gender:

Summary

The present study was an open-label, uncontrolled, and multi-centered phase III clinical trial for evaluation of the efficacy (clinical efficacy and hemodynamics) and safety of nesiritide.

Phase:

Phase 3

Details

Lead Sponsor:

Xian-Janssen Pharmaceutical Ltd.

Treatments:

Natriuretic Peptide, Brain